News
Article
Sponsored Content
Get Ready, Pharma: How Point-Of-Care AI Could Transform Commercial Strategy While Improving Patient Outcomes
Author(s):
Pharma leaders are increasingly allocating budget toward real-time clinical alerts that integrate with and improve patient care. By investing in algorithms that auto-detect diseases as common as heart failure and as rare as pulmonary arterial hypertension, manufacturers can help accelerate time to diagnosis and treatment, streamline monitoring and identify new patients while starting them on the right therapies faster.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Related Content
